Xu Liu
Guangxi Key Laboratory Of Special Biomedicine
Nanning, China
Nanning, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Evaluation of therapeutic efficacy in hepatocellular carcinoma ablation based on CT radiomics and deep learning multimodal models.
Journal: Frontiers in oncology
Published: December 09, 2025
Preparation of Dual-Drug-Loaded Liver-Targeted Liposomes Co-Modified with SP94 Peptide and TAT Peptide.
Journal: Current drug delivery
Published: December 18, 2024
Preparation of double-loaded bitter ginseng derivative B21-DOX liposomes co-modified with SP94 and BR2 ligand and its in vitro anti-hepatocarcinogenic effect.
Journal: Journal of microencapsulation
Published: August 16, 2024
Investigation of Dual-Loaded Doxorubicin and Sorafenib Liposomes Co-Modified with Glycyrrhetinic Acid and Cell-Penetrating Peptide TAT.
Journal: Current drug delivery
Published: April 03, 2024
Novel chiral matrine derivatives as potential antitumor agents: Design, synthesis and biological evaluation.
Journal: Bioorganic chemistry
Published: January 22, 2024
Induction of Apoptosis by Matrine Derivative ZS17 in Human Hepatocellular Carcinoma BEL-7402 and HepG2 Cells through ROS-JNK-P53 Signalling Pathway Activation.
Journal: International journal of molecular sciences
Published: November 21, 2022
Design, synthesis and biological evaluation of 1,4-dihydroxyanthraquinone derivatives as anticancer agents.
Journal: Bioorganic & medicinal chemistry letters
Published: October 16, 2018
Novel indolo-sophoridinic scaffold as Topo I inhibitors: Design, synthesis and biological evaluation as anticancer agents.
Journal: European journal of medicinal chemistry
Published: May 22, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026